Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Insulin secretion stimulators in development Merck KGaA for type 2 diabetes therapy

Dec. 24, 2009

Novel GK activators for the treatment of diabetes presented by Roche

Dec. 24, 2009

Bristol-Myers Squibb claims DGAT-1 inhibitors for the treatment of obesity

Dec. 24, 2009

Cardium reports results from 10-year follow-up study of diabetic patients with foot ulcer

Dec. 23, 2009

European CHMP recommends marketing authorization of Amgen's Prolia for osteoporosis

Dec. 23, 2009

Fusion protein ACE-435 shows promise in cancer-induced cachexia therapy

Dec. 23, 2009

Novel enzyme replacement therapy for Fabry disease in preclinical development

Dec. 23, 2009

Unigene selects obesity drug UGP-281 as lead compound for development

Dec. 23, 2009

CB1 antagonists for the treatment of obesity described by sanofi-aventis

Dec. 22, 2009

Eisai to acquire AkaRx and thrombocytopenia therapeutic AKR-501

Dec. 22, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...